Dr. Beth Renee Santmyire-rosenberger, MD PHD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1812 Country Club Rd, Ste 201, Fairmont, WV 26554 Phone: 304-368-0111 Fax: 304-368-0411 |
News Archive
News outlets analyze arguments around the individual mandate and what a ruling by the Supreme Court will mean for most Americans. Kaiser Health News looks at changes in the health care industry as a result of the law, and how most of those shifts will continue regardless of what the Court decides.
A few months ago, the boxy, teal truck parked outside a McDonald's in this Inland Empire city might have drawn hundreds of people willing to stand in line for hours under the scorching sun.
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, announced today the publication of two new review papers in the area of epigenetics. Together, the articles provide an overview of the major epigenetic enzyme classes, as well as chemical biology approaches for discovering small molecule inhibitors of these epigenetic enzymes, and demonstrate Epizyme's scientific leadership in the area of epigenetics.
Dr. Karen Newell, Ph. D., the lead researcher for bio technology company Viral Genetics (Pink Sheets: VRAL), will address the 4th Annual Aspen Symposium on Brain Tumor Immuno- and Stem Cell Therapy. Her presentation will highlight the potential for combining chemotherapy with compounds that interfere with the ability of brain tumor cells to generate the energy needed to repair chemotherapy induced DNA damage.
› Verified 2 days ago